Several years ago, a relatively new catalyst for vehicle emission control began showing failure. A team at PNNL found that this seemingly suicidal catalyst wasn’t actually self-destructing but was the victim of an external assailant.
One of the most common and deadly complications from a heart attack is kidney failure. New research indicates that a specific protein in the bloodstream created after cardiac arrest may be the culprit...
Our gut’s microbial community is not unlike a country club membership. We know who’s a member, but we may not know how each contributes to the overall function or health of the club....
A detailed analysis of blood samples from Ebola patients in Sierra Leone is providing clues about the progression of the effects of the virus and potential treatment pathways. The findings point to a critical role for a molecular pathway.
Pacific Northwest National Laboratory and Washington State University researchers have developed a novel way to deliver drugs and therapies into cells at the nanoscale without causing toxic effects that have stymied other such efforts.
Center for Molecular Electrocatalysis thrust lead for heterogeneous interfaces, Dr. James “Jim” Mayer, was recently honored with the Frontiers Award by the Max Planck Institute for Chemical Energy Conversion.
Scientists at PNNL's Center for Molecular Electrocatalysis (CME) are working to understand the fundamental reactivity of H2 that could contribute to making hydrogen a more widely used fuel source.
Researchers developed a new hybrid catalyst that achieved chemo-selective and site-selective hydrogenation of aromatic molecules under low pressure of dihydrogen and mild temperature.
